Hangzhou Leap Chem Co., Ltd. yog ib qho ntawm cov kws tshaj lij thiab cov neeg muag khoom ntawm sorafenib tosylate 丨cas 475207-59-1 hauv Suav teb. Txais tos rau kev lag luam wholesale kev cai ua cov khoom lag luam ntawm tus nqi sib tw los ntawm peb lub hoobkas. Rau cov khoom pheej yig dua, tiv tauj peb tam sim no.
Specifications
| Qhov tshwm sim | Dawb los yog daj hmoov |
| Purity | 99.0% min. |
| Kev txheeb xyuas | HPLC |
| Residue ntawm ignition | 0.5% max. |
| Poob rau ziab | 1.0% max. |
| Tag nrho impurity | 1.0% max. |
| Ib leeg impurity | 0.5% max. |
Cov ntaub ntawv thauj mus los
|
Parameter |
Specification |
|
UN Number |
3077 |
|
Chav kawm |
9 |
|
Packing Group |
III |
|
HS Code |
3004909093999 |
|
Stability & Reactivity |
Cov khoom yog chemically ruaj khov nyob rau hauv tus qauv ambient tej yam kev mob. |
|
Cia |
Tightly kaw. Qhuav. Khaws rau hauv qhov chaw zoo- qhov cua. Khaws cia los yog nyob rau hauv ib qho chaw nkag tau rau cov neeg tsim nyog lossis cov neeg muaj cai. Cia ruaj khov Pom zoo cia kub -20℃Cia chav kawm |
|
Qhov xwm txheej kom zam |
|
|
Pob |
Cov ntaub ntawv tsim khoom
|
Parameter |
Specification |
|
Muaj peev xwm |
100kg / hli |
|
Ntau zaus |
|
|
Main Export Lub teb chaws |
|
|
Peev xwm / Batch |
|
|
Kev paub |
Kev tsim tawm txij li xyoo 2016 |
|
Tshuag |
Daim ntawv thov
Sorafenib tosylate feem ntau yog siv nyob rau hauv kev lag luam kws tshuaj raws li ib tug multikinase inhibitor rau kev kho mob ntawm ntau yam qog nqaij hlav, xws li mob raum cell carcinoma, hepatocellular carcinoma, thiab txawv thyroid carcinoma. Nws ua haujlwm los ntawm inhibiting qog cell proliferation thiab angiogenesis los ntawm kev tsom ntau kinases koom nrog hauv RAF / MEK / ERK txoj hauv kev thiab receptor tyrosine kinases xws li VEGFR thiab PDGFR. Hauv kev tshawb fawb, Sorafenib tosylate yog siv los kawm kinase signaling pathways, cancer cell loj hlob, angiogenesis mechanisms, thiab kev loj hlob ntawm tshiab anticancer kho. Nws kuj tseem ua haujlwm hauv kev tsim tshuaj rau kev tshuaj xyuas ua ntej ntawm kev sib xyaw ua ke thiab cov txheej txheem tiv thaiv hauv oncology.
Cov txiaj ntsig
Sorafenib tosylate muaj ntau yam zoo hauv kev kho mob thiab kev tshawb fawb. Nws lub peev xwm los tsom ntau yam kinases ib txhij tso cai rau kev tua cov qog loj hlob thiab angiogenesis, ua rau nws muaj peev xwm kho mob rau ntau yam qog noj ntshav. Daim ntawv tosylate txhim kho solubility thiab stability, yooj yim formulation rau hauv qhov ncauj ntau npaum cov ntaub ntawv. Nws zoo-cov tshuaj pharmacokinetics thiab cov khoom siv bioactivity rov ua tau zoo txhawb nqa cov txiaj ntsig kev kho mob thiab kev tshawb fawb ua ntej. Tsis tas li ntawd, Sorafenib tosylate yog ib qho cuab yeej tseem ceeb hauv kev tshawb fawb rau kev tshawb nrhiav kinase inhibition, cov tswv yim kho mob ua ke, thiab cov txheej txheem ntawm cov tshuaj tiv thaiv, pab txhawb kev nce qib ntawm kev kho mob qog noj ntshav.
Xaus
Sorafenib tosylate yog multikinase inhibitor nrog rau kev siv hauv kev kho mob qog noj ntshav, kev tshawb fawb tshuaj, thiab kev tsim tshuaj. Nws lub hom phiaj kev ua ub no, solubility, thiab tsim kom muaj txiaj ntsig ua rau nws muaj txiaj ntsig hauv ob qho tib si kho mob thiab kev tshawb fawb preclinical. Zuag qhia tag nrho, Sorafenib tosylate txhawb nqa cov qog nqaij hlav zoo, tshawb nrhiav txoj hauv kev kinase, thiab kev txhim kho cov tswv yim tiv thaiv kab mob siab heev.
Cim npe nrov: Tuam Tshoj sorafenib tosylate 丨cas 475207-59-1, Tuam Tshoj sorafenib tosylate 丨cas 475207-59-1 manufacturers, lwm tus neeg, Hoobkas
